• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肢端肥大症的病理生理学

Pathophysiology of acromegaly.

作者信息

Melmed S, Braunstein G D, Horvath E, Ezrin C, Kovacs K

出版信息

Endocr Rev. 1983 Summer;4(3):271-90. doi: 10.1210/edrv-4-3-271.

DOI:10.1210/edrv-4-3-271
PMID:6354702
Abstract

This review discusses the pathophysiology of acromegaly. Acromegaly has been classified in this paper into distinct entities based on etiology, ultrastructural features of the pituitary, and cytogenesis. This classification has been proposed based on clinical signs, immunoperoxidase techniques, transmission electromicroscopy and immunoelectron microscopy. Pituitary causes of acromegaly include densely granulated adenomas, sparsely granulated adenomas, mixed growth hormone and prolactin cell adenomas, acidophil stem cell adenomas, mammosomatotroph cell adenomas, and pleurihormonal adenomas. GH cell hyperplasia and GH cell carcinoma are also discussed. Extrapituitary causes of acromegaly include eutopic GH cell adenoma in the sphenoid sinus or parapharyngeal region and excess GHRF secretion which may be eutopic or ectopic. The pathological, clinical, and biochemical evidence in favor of a pituitary or hypothalamic etiology of acromegaly has been reviewed. Finally, a multistage theory of GH cell tumorigenesis has been proposed as a model in an attempt to unify the genetic, environmental and biochemical factors implicated in the pathogenesis of acromegaly.

摘要

本综述讨论了肢端肥大症的病理生理学。本文根据病因、垂体的超微结构特征和细胞发生情况,将肢端肥大症分为不同的类型。这种分类是基于临床体征、免疫过氧化物酶技术、透射电子显微镜和免疫电子显微镜提出的。肢端肥大症的垂体病因包括密集颗粒型腺瘤、稀疏颗粒型腺瘤、生长激素和催乳素混合细胞腺瘤、嗜酸性干细胞腺瘤、促乳腺生长素细胞腺瘤和多激素腺瘤。还讨论了生长激素细胞增生和生长激素细胞癌。肢端肥大症的垂体外病因包括蝶窦或咽旁区域的异位生长激素细胞腺瘤以及生长激素释放因子分泌过多,后者可能是异位的或正常位置的。本文回顾了支持肢端肥大症的垂体或下丘脑病因的病理、临床和生化证据。最后,提出了生长激素细胞瘤发生的多阶段理论作为一个模型,试图统一与肢端肥大症发病机制相关的遗传、环境和生化因素。

相似文献

1
Pathophysiology of acromegaly.肢端肥大症的病理生理学
Endocr Rev. 1983 Summer;4(3):271-90. doi: 10.1210/edrv-4-3-271.
2
A clinicomorphological study of pituitary tumors associated with the clinical syndrome of acromegaly.与肢端肥大症临床综合征相关的垂体肿瘤的临床形态学研究
Exp Clin Endocrinol. 1991;98(3):223-7. doi: 10.1055/s-0029-1211121.
3
Growth hormone-secreting adenomas: pathology and cell biology.生长激素分泌腺瘤:病理学与细胞生物学。
Neurosurg Focus. 2010 Oct;29(4):E2. doi: 10.3171/2010.7.FOCUS10169.
4
Pathology of growth hormone-producing tumors of the human pituitary.人类垂体生长激素分泌肿瘤的病理学
Semin Diagn Pathol. 1986 Feb;3(1):18-33.
5
Pathology of acromegaly.肢端肥大症的病理学
Neuroendocrinology. 2006;83(3-4):161-5. doi: 10.1159/000095524. Epub 2006 Oct 13.
6
Morphological and biochemical relationships in 31 human pituitary adenomas with acromegaly.31例肢端肥大症患者垂体腺瘤的形态学与生化关系
Virchows Arch A Pathol Anat Histol. 1980;389(2):127-42. doi: 10.1007/BF00439481.
7
Structure-function correlations of growth hormone or/and prolactin-producing pituitary adenomas: an in vitro study with the reverse hemolytic plaque assay.生长激素或/和泌乳素分泌型垂体腺瘤的结构-功能相关性:反向溶血空斑试验的体外研究
J Endocrinol Invest. 1999 Oct;22(9):671-80. doi: 10.1007/BF03343628.
8
Growth hormone-secreting pituitary adenoma of mixed cell type: a histological, ultrastructural and immunocytochemical study.混合细胞型生长激素分泌性垂体腺瘤:一项组织学、超微结构及免疫细胞化学研究
Clin Neuropathol. 1986 Jan-Feb;5(1):28-33.
9
Pituitary adenoma in Carney complex: an immunohistochemical, ultrastructural, and immunoelectron microscopic study.卡尼综合征中的垂体腺瘤:一项免疫组织化学、超微结构及免疫电子显微镜研究
Ultrastruct Pathol. 2002 Nov-Dec;26(6):345-53. doi: 10.1080/01913120290104656.
10
Pituitary pathology in acromegaly.肢端肥大症中的垂体病理学
Endocrinol Metab Clin North Am. 1992 Sep;21(3):553-74.

引用本文的文献

1
A single-center prospective study evaluating the relationship of tumor consistency on remission in acromegaly patients.一项评估肢端肥大症患者肿瘤质地与缓解关系的单中心前瞻性研究。
Sci Rep. 2025 Jan 6;15(1):868. doi: 10.1038/s41598-025-85331-5.
2
[Unification of pathomorphological examination of patients with neuroendocrine tumors of the pituitary gland. Controversial issues of the new classification].[垂体神经内分泌肿瘤患者病理形态学检查的统一。新分类的争议问题]
Probl Endokrinol (Mosk). 2023 Nov 14;70(3):31-45. doi: 10.14341/probl13376.
3
Acromegaly: Pathophysiological Considerations and Treatment Options Including the Evolving Role of Oral Somatostatin Analogs.
肢端肥大症:病理生理学考量与治疗选择,包括口服生长抑素类似物的不断演变的作用
Pathophysiology. 2023 Sep 1;30(3):377-388. doi: 10.3390/pathophysiology30030029.
4
Clinical and prognostic significance of granulation patterns in somatotroph adenomas/tumors of the pituitary: a meta-analysis.垂体生长激素腺瘤/肿瘤中颗粒模式的临床和预后意义:一项荟萃分析。
Pituitary. 2023 Dec;26(6):653-659. doi: 10.1007/s11102-023-01353-0. Epub 2023 Sep 21.
5
Molecular targets in acromegaly.肢端肥大症的分子靶点。
Front Endocrinol (Lausanne). 2022 Dec 5;13:1068061. doi: 10.3389/fendo.2022.1068061. eCollection 2022.
6
Clinical Biology of the Pituitary Adenoma.垂体腺瘤的临床生物学。
Endocr Rev. 2022 Nov 25;43(6):1003-1037. doi: 10.1210/endrev/bnac010.
7
Clinical, biological, radiological, and pathological comparison of sparsely and densely granulated somatotroph adenomas: a single center experience from a cohort of 131 patients with acromegaly.肢端肥大症患者稀疏颗粒型和密集颗粒型生长激素腺瘤的临床、生物学、影像学和病理学比较:来自 131 例肢端肥大症患者队列的单中心经验
Pituitary. 2021 Apr;24(2):192-206. doi: 10.1007/s11102-020-01096-2. Epub 2020 Oct 19.
8
REDUCTION IN THYMOMA SIZE AFTER PITUITARY SURGERY FOR GROWTH HORMONE-SECRETING TUMOR.垂体手术治疗生长激素分泌型肿瘤后胸腺瘤体积缩小
AACE Clin Case Rep. 2018 Nov 1;5(2):e164-e167. doi: 10.4158/ACCR-2018-0288. eCollection 2019 Mar-Apr.
9
International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature.国际基础和临床药理学联合会。生长抑素受体:结构、功能、配体和新命名。
Pharmacol Rev. 2018 Oct;70(4):763-835. doi: 10.1124/pr.117.015388.
10
Oro-dental pathologies in acromegaly.肢端肥大症的口腔-牙科病变。
Endocrine. 2018 May;60(2):323-328. doi: 10.1007/s12020-018-1571-y. Epub 2018 Mar 8.